The following is a summary of “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic ...

A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic hand eczema achieved a ...

Some might see what they think is stress-related eczema on their hands, but the cause of hand ... it can be managed with treatment. Available treatments for atopic eczema have significantly ...

A new survey commissioned by Leo Pharma confirms there’s plenty of room in the market for its chronic hand eczema treatment Anzupgo, which is currently under review by the FDA. The survey ...

Eczema, on the other hand, is a long-term, chronic condition that needs ongoing treatment and symptom management. Although the two conditions may have some similarities in their appearance ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Eczema outbreaks often ... drugs used for cancer treatment. It’s characterized by pain, swelling, and skin discoloration in the palms and soles of the hands and feet. It can also cause tingling ...

There is currently no FDA-approved treatment for CHE. “Chronic hand eczema, often abbreviated as ‘CHE,’ is one of the most common skin disorders of the hands. Affecting about 15.9 million ...

1 The findings from the post hoc analysis highlight that delgocitinib cream produced a strong treatment response across this subgroup of patients. A deep response, defined as a Hand Eczema Symptom ...

The post hoc analysis investigated treatment responses in a patient subgroup with moderate to severe Chronic Hand Eczema (CHE) treated with delgocitinib cream for 16 weeks in the DELTA 1 2 phase 3 ...